Time to put an end to the "one size fits all" approach to bisphosphonate use in patients with metastatic breast cancer?
about
Future directions for bone metastasis research - highlights from the 2015 bone and the Oncologist new updates conference (BONUS)Systemic treatment approaches in her2-negative advanced breast cancer-guidance on the guidelinesPublishing clinical research: ten pearls for oncology trainees and junior oncologists.Bone-Targeted Agents for the Management of Breast Cancer Patients with Bone MetastasesDe-escalated administration of bone-targeted agents in patients with breast and prostate cancer-A survey of Canadian oncologists.Incidence, consequences and treatment of bone metastases in breast cancer patients-Experience from a single cancer centre.A systematic review of dosing frequency with bone-targeted agents for patients with bone metastases from breast cancer.Bone-targeted agent use for bone metastases from breast cancer and prostate cancer: A patient survey.Bone-targeted therapy for metastatic breast cancer-Where do we go from here? A commentary from the BONUS 8 meeting.A phase 2 trial exploring the clinical and correlative effects of combining doxycycline with bone-targeted therapy in patients with metastatic breast cancer.A phase II, multicentre trial evaluating the efficacy of de-escalated bisphosphonate therapy in metastatic breast cancer patients at low-risk of skeletal-related events.Efficacy and safety of de-escalation bone- modifying agents for cancer patients with bone metastases: a systematic review and meta-analysis
P2860
Q26747566-79D2543D-9ADB-44E8-BD57-4B425980E678Q28080469-14D231BD-5250-49B1-B0FB-E32EE91D5F95Q35072451-96802A6C-E194-4001-92BC-B814B6C44D30Q35750641-C20C6E6F-22F2-46F4-A2AD-139004E0FC50Q36491477-0F235601-8EB7-4E03-B7B3-B003E78F2899Q36491533-ADA02102-B76F-41EC-A90D-560F1EA1E82EQ36491537-48600A41-3639-4744-81FA-50854C51CB0CQ36491601-3F7E0BC5-45FC-494C-96D9-708CF1F3442DQ36491642-BEC027C2-F487-4F6E-B970-C165CDE861E2Q37499970-73618AE5-28BF-4749-8B8E-B0A24B1193F7Q37656386-7869B496-AF9C-412E-A3C4-1F748BDD526CQ57071021-5330809C-78D0-461E-AEF9-225697864923
P2860
Time to put an end to the "one size fits all" approach to bisphosphonate use in patients with metastatic breast cancer?
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Time to put an end to the "one ...... with metastatic breast cancer?
@ast
Time to put an end to the "one ...... with metastatic breast cancer?
@en
type
label
Time to put an end to the "one ...... with metastatic breast cancer?
@ast
Time to put an end to the "one ...... with metastatic breast cancer?
@en
prefLabel
Time to put an end to the "one ...... with metastatic breast cancer?
@ast
Time to put an end to the "one ...... with metastatic breast cancer?
@en
P2093
P2860
P356
P1433
P1476
Time to put an end to the "one ...... with metastatic breast cancer?
@en
P2093
P2860
P304
P356
10.3747/CO.19.1009
P577
2012-10-01T00:00:00Z